Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Advances in Therapy|July 11, 2024
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2Claire N Harrison, Alessandro M Vannucchi, Christian Recher, et al.
The Journal of Infection|July 2, 2023
Whole-genome sequencing reveals widespread presence of Staphylococcus capitis NRCS-A clone in neonatal units across the United KingdomYu Wan, Mark Ganner, Zaynab Mumin, et al.
Infection Prevention in Practice|September 22, 2025
Understanding the landscape of carbapenemase-producing organisms (CPOs), and spotlighting opportunities for control in EnglandAkaninyene Otu, Jacquelyn McCormick, Katherine L Henderson, et al.
Journal of Clinical Microbiology|June 5, 2015
High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United KingdomJane F Turton, Laura Wright, Anthony Underwood, et al.
Annals of Surgical Oncology|April 25, 2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancerUday Bharat Patel, Gina Brown, Harm Rutten, et al.
Indian Journal of Dermatology, Venereology and Leprology|February 8, 2026
Standardising the diagnosis and management of atopic dermatitis in India: A consensus statement by the modified Delphi method by IADVL Special Interest Group of Pediatric Dermatology (STAND AD)Rashmi Sarkar, Liza Mohapatra, Divya Gupta, et al.
British Journal of Cancer|May 17, 2025
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa studyTimothy A Yap, Patricia LoRusso, Rowan E Miller, et al.
BMJ Open|February 19, 2021
Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020Guduru Gopal Rao, Alexander Allen, Padmasayee Papineni, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 11, 2026
Spleen Volume Reduction and Transfusion Independence With Momelotinib Versus Ruxolitinib and Associated Overall Survival With Momelotinib in JAK Inhibitor-Naive Patients With Myelofibrosis and Anemia: Subgroup Analyses of SIMPLIFY-1Francesca Palandri, Nicolaas P M Schaap, Jerome Rey, et al.
Journal of Medical Microbiology|May 21, 2024
The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in EnglandChristopher R Jones, Claire Neill, Andrew M Borman, et al.
Pageof 8